Inventor · disambiguated record
Dominik Maurer
Also filed as: MAURER DOMINIK
38 granted patents·31 pending applications·269 citations·filing 2016–2025
97Inventor score
Files withIMMATICS BIOTECHNOLOGIES GMBH63IMMATICS US INC2TRUMPF LASER & SYSTEMTECHNIK GMBH2TECAN TRADING AG1TRUMPF LASER & SYSTEMTECHNIK SE1
Top patents by PatentIndex Score
69 records- 0198US11111294B2T cell receptors and immune therapy using the sameIMMATICS BIOTECHNOLOGIES GMBH·Filed 2020·Granted Sep 7, 2021·11 cites·15 claims
- 0298US10723796B2T cell receptors and immune therapy using the sameIMMATICS BIOTECHNOLOGIES GMBH·Filed 2019·Granted Jul 28, 2020·22 cites·20 claims
- 0398US10590194B2T cell receptors and immune therapy using the sameIMMATICS BIOTECHNOLOGIES GMBH·Filed 2018·Granted Mar 17, 2020·23 cites·17 claims
- 0497US10889629B2Transfected T-cells and T-cell receptors for use in immunotherapy against cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2020·Granted Jan 12, 2021·4 cites·20 claims
- 0597US10800832B2T cell receptors and immune therapy using the same against prame positive cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2019·Granted Oct 13, 2020·19 cites·14 claims
- 0697US10800845B2T cell receptors and immune therapy using the sameIMMATICS BIOTECHNOLOGIES GMBH·Filed 2019·Granted Oct 13, 2020·12 cites·19 claims
- 0797US10725044B2T cell receptors and immune therapy using the sameIMMATICS BIOTECHNOLOGIES GMBH·Filed 2018·Granted Jul 28, 2020·12 cites·30 claims
- 0897US10702609B2T cell receptors and immune therapy using the sameIMMATICS BIOTECHNOLOGIES GMBH·Filed 2019·Granted Jul 7, 2020·14 cites·33 claims
- 0997US10626160B2Transfected T-cells and T-cell receptors for use in immunotherapy against cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2019·Granted Apr 21, 2020·14 cites·20 claims
- 1097US10596242B2Transfected T-cells and T-cell receptors for use in immunotherapy against cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2019·Granted Mar 24, 2020·12 cites·20 claims
- 1197US10550182B2T cell receptors and immune therapy using the sameIMMATICS BIOTECHNOLOGIES GMBH·Filed 2017·Granted Feb 4, 2020·15 cites·8 claims
- 1297US10526407B2T cell receptors and immune therapy using the sameIMMATICS BIOTECHNOLOGIES GMBH·Filed 2018·Granted Jan 7, 2020·17 cites·24 claims
- 1397US10527623B2T cell receptors and immune therapy using the sameIMMATICS BIOTECHNOLOGIES GMBH·Filed 2017·Granted Jan 7, 2020·13 cites·9 claims
- 1496US10618956B2Engineered T cell receptors and immune therapy using the sameIMMATICS BIOTECHNOLOGIES GMBH·Filed 2018·Granted Apr 14, 2020·13 cites·16 claims
- 1595US11104894B2Method for preparing electrocompetent yeast cells, and method for using said cellsIMMATICS BIOTECHNOLOGIES GMBH·Filed 2020·Granted Aug 31, 2021·3 cites·18 claims
- 1695US11072645B2T cell receptors with improved pairingIMMATICS BIOTECHNOLOGIES GMBH·Filed 2017·Granted Jul 27, 2021·10 cites·5 claims
- 1795US10538573B2Transfected T-cells and T-cell receptors for use in immunotherapy against cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2017·Granted Jan 21, 2020·20 cites·21 claims
- 1894US10889645B2Engineered T cell receptors and immune therapy using the sameIMMATICS BIOTECHNOLOGIES GMBH·Filed 2020·Granted Jan 12, 2021·3 cites·20 claims
- 1993US10537624B2Transfected T-cells and T-cell receptors for use in immunotherapy against cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2017·Granted Jan 21, 2020·15 cites·13 claims
- 2091US10874731B2T cell receptors and immune therapy using the sameIMMATICS BIOTECHNOLOGIES GMBH·Filed 2017·Granted Dec 29, 2020·4 cites·15 claims
- 2190US11840577B2Antigen binding proteins specifically binding MAGE-AIMMATICS BIOTECHNOLOGIES GMBH·Filed 2020·Granted Dec 12, 2023·2 cites·9 claims
- 2290US2025154246A1Novel t cell receptors and immune therapy using the sameIMMATICS BIOTECHNOLOGIES GMBH·Filed 2024·Application pending·0 cites
- 2389US11236145B2T cell receptors and immune therapy using the same against PRAME positive cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2018·Granted Feb 1, 2022·3 cites·25 claims
- 2489US11111286B2T cell receptors and immune therapy using the same against PRAME positive cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2019·Granted Sep 7, 2021·3 cites·20 claims
- 2589US10683495B2Method for preparing electrocompetent yeast cells, and method for using said cellsIMMATICS BIOTECHNOLOGIES GMBH·Filed 2017·Granted Jun 16, 2020·3 cites·19 claims
- 2686US2025361300A1Improved dual specificity polypeptide moleculeIMMATICS BIOTECHNOLOGIES GMBH·Filed 2025·Application pending·0 cites
- 2784US2024279308A1Transfected t-cells and t-cell receptors for use in immunotherapy against cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2024·Application pending·0 cites
- 2884US2023348598A1Improved dual specificity polypeptide moleculeIMMATICS BIOTECHNOLOGIES GMBH·Filed 2023·Application pending·0 cites
- 2984US2024228611A1Novel engineered t cell receptors and immune therapy using the sameIMMATICS BIOTECHNOLOGIES GMBH·Filed 2024·Application pending·0 cites
- 3083US12269881B2Antigen binding proteins specifically binding MAGE-AIMMATICS BIOTECHNOLOGIES GMBH·Filed 2023·Granted Apr 8, 2025·0 cites·8 claims
- 3183US11458573B2Layer selective exposure in the overhang region in generative manufacturingTRUMPF LASER & SYSTEMTECHNIK GMBH·Filed 2020·Granted Oct 4, 2022·2 cites·19 claims
- 3282US2023321208A1Transfected t-cells and t-cell receptors for use in immunotherapy against cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2023·Application pending·0 cites
- 3381US2024285779A1Novel t cell receptors and immune therapy using the sameIMMATICS BIOTECHNOLOGIES GMBH·Filed 2024·Application pending·0 cites
- 3479US2024052054A1Antigen binding proteins specifically binding mage-aIMMATICS BIOTECHNOLOGIES GMBH·Filed 2023·Application pending·0 cites
- 3578US2022185888A1Dual specificity polypeptide moleculeIMMATICS BIOTECHNOLOGIES GMBH·Filed 2022·Application pending·0 cites
- 3678US2022195044A1Dual specificity polypeptide moleculeIMMATICS BIOTECHNOLOGIES GMBH·Filed 2022·Application pending·0 cites
- 3777US11859009B2Antigen binding proteins specifically binding PRAMEIMMATICS BIOTECHNOLOGIES GMBH·Filed 2022·Granted Jan 2, 2024·0 cites·30 claims
- 3877US2024092933A1Antigen binding proteins specifically binding prameIMMATICS BIOTECHNOLOGIES GMBH·Filed 2023·Application pending·0 cites
- 3977US2025122302A1Antigen binding proteins specifically binding ct45IMMATICS BIOTECHNOLOGIES GMBH·Filed 2024·Application pending·0 cites
- 4076US2021388079A1Novel t cell receptors and immune therapy using the sameIMMATICS BIOTECHNOLOGIES GMBH·Filed 2021·Application pending·0 cites
- 4175US11945854B2Transfected T-cells and T-cell receptors for use in immunotherapy against cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2020·Granted Apr 2, 2024·0 cites·20 claims
- 4275US11932689B2Engineered T cell receptors and immune therapy using the sameIMMATICS BIOTECHNOLOGIES GMBH·Filed 2020·Granted Mar 19, 2024·0 cites·20 claims
- 4375US2025019406A1Sorting with counter selection using sequence similar peptidesIMMATICS BIOTECHNOLOGIES GMBH·Filed 2024·Application pending·0 cites
- 4475US2023357428A1Antigen binding proteins specifically binding prameIMMATICS BIOTECHNOLOGIES GMBH·Filed 2023·Application pending·0 cites
- 4573US12209137B2Antigen binding proteins specifically binding CT45IMMATICS BIOTECHNOLOGIES GMBH·Filed 2022·Granted Jan 28, 2025·0 cites·64 claims
- 4673US11730796B2Transfected t-cells and t-cell receptors for use in immunotherapy against cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2020·Granted Aug 22, 2023·0 cites·24 claims
- 4773US2025332789A1Additive manufacturing device and preparation methodTRUMPF LASER & SYSTEMTECHNIK SE·Filed 2025·Application pending·0 cites
- 4872US12297252B2T cell receptors with improved pairingIMMATICS BIOTECHNOLOGIES GMBH·Filed 2021·Granted May 13, 2025·0 cites·10 claims
- 4970US2025215084A1Antigen binding proteins specifically binding mage-aIMMATICS BIOTECHNOLOGIES GMBH·Filed 2025·Application pending·0 cites
- 5069US11998607B2T cell receptors and immune therapy using the sameIMMATICS BIOTECHNOLOGIES GMBH·Filed 2020·Granted Jun 4, 2024·0 cites·25 claims
Showing the top 50 of 69 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Dominik Maurer files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →